PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

2014-01-24
(Press-News.org) Contact information: Sophia Haque
sophia.haque@rhul.ac.uk
01-784-443-552
Royal Holloway, University of London
Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

Scientists have discovered the use of a simple single-celled amoeba to understand the function of human proteins in causing Alzheimer's disease.

The new study, published in the Journal of Cell Science today (Friday 24 January) by researchers at Royal Holloway, University of London and the Institute of Psychiatry King's College London, reveals how the amoeba will enable a better understanding of the function of these Alzheimer's disease-associated proteins in the cell without the need for testing on animals, with the ultimate aim of developing improved treatments for the degenerative disease.

Mutations in presenilin proteins cause inherited forms of Alzheimer's disease, and these proteins also play a major role in the age-related onset of the condition.

However, understanding the role of these proteins is difficult, since cells lacking the proteins are non-viable.

Presenilin proteins have been extensively analysed and animals are commonly used in this research area, but these experiments are problematic since deletion of the proteins in animal cells causes a loss of viability and blocks the development.

"This discovery allows us to examine the role for the human presenilin 1 protein, without the use of animal testing. It is amazing that so simple an organism lends itself to the study of such a complex disease," says Professor Robin Williams from the School of Biological Sciences at Royal Holloway.

"This work on the amoeba Dictyostelium shows we can successfully use this simple model to try to better understand the normal roles of other proteins and genes involved in Alzheimer's disease and other forms of neurodegeneration," added Dr Richard Killick from the Institute of Psychiatry King's College London.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Central Europeans already digested milk as well as us 1,000 years ago

2014-01-24
Back in the Middle Ages, Central Europeans were already capable of digesting milk, yoghurt and cheese just as well as us today. Researchers at the University of Zurich's Centre for ...

Generation blame: How age affects our views of anti-social behavior

2014-01-24
A study of interpretations of anti-social behaviour (ASB) found a significant gap between the views of different age groups - with older people more likely than younger people to interpret ...

Changing climate: How dust changed the face of the earth

2014-01-24
Bremerhaven/Germany, 24 January 2014. In spring 2010, ...

World's first magma-enhanced geothermal system created in Iceland

2014-01-24
RIVERSIDE, Calif. — In 2009, a borehole drilled at Krafla, ...

Using engineering plus evolutionary analyses to answer natural selection questions

2014-01-24
AMHERST, Mass. – Introducing a new approach that combines evolutionary and engineering analyses to identify the targets of natural selection, researchers ...

Various microstructures fabricated by a solvent-cast 3-D printing technique

2014-01-24
Various microstructures including straight filaments, layer-by-layer ...

Researchers discover potential drug targets for early onset glaucoma

2014-01-24
Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that ...

National plan for preventing healthcare-associated infections shows progress

2014-01-24
Philadelphia, Pa. (January 23, 2014) – Independent evaluators have found that measurable ...

The lung microbiome: A new frontier in pulmonary medicine

2014-01-24
The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine." ...

Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers

2014-01-24
NEW YORK, NY (January 23, 2014) — Survivors of breast cancer have a one in ...

LAST 30 PRESS RELEASES:

Postoperative complications of medical tourism may cost NHS up to £20,000/patient

Phone apps nearly 3 times as good as no/basic support for quitting smoking long term

Female sex and higher education linked to escalating prevalence of obesity and overweight in Africa

THE LANCET + eCLINICALMEDICINE: Two studies on reductions in mortality from small changes lifestyle changes

AI model identifies how every country can improve its cancer outcomes

Young people risk drifting into serious online offenses through a slippery slope of high-risk digital behavior

Implant provides lasting relief for treatment-resistant depression

Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer

First extensive study into marsupial gut microbiomes reveals new microbial species and antimicrobial resistance

Study debunks myth of native Hawaiians causing bird extinctions

Tailored biochar could transform how crops grow, resist disease, and clean polluted soils

Biochar-based enzyme technology offers new path for cleaner water and soil

Biochar helps farmland soils withstand extreme rain and drought by steadying carbon loss

New study reveals major gaps in global forest maps

Ochsner Health names Dr. Timothy Riddell executive vice president and chief operating officer

Can future-focused thoughts help smokers quit?

From brain scans to alloys: Teaching AI to make sense of complex research data

Stem Cell Reports seeks early career editors to join the editorial board

Signs of ancient life turn up in an unexpected place

Pennington Biomedical researchers explore factors behind body’s ability to regulate weight

Zhongping Lee awarded the Nils Gunnar Jerlov Medal

Deborah S. Kelley awarded the Wallace S. Broecker Medal

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

LLM treatment advice agrees with physician recommendations in early-stage HCC, but falls short in late stage

Deep learning model trained with stage II colorectal cancer whole slide images identifies features associated with risk of recurrence – with higher success rate than clinical prognostic parameters

Aboard the International Space Station, viruses and bacteria show atypical interplay

Therapies that target specific type of cell death may be an effective avenue for cancer treatment, UTHealth Houston researchers find

CHEST releases guideline on biologic management in severe asthma

Scientists create a system for tracking underwater blackouts

Fruit fly pigmentation guides discovery of genes that control brain dopamine and sleep

[Press-News.org] Researchers discover simple amoeba holds the key to better treatment for Alzheimer's